FDA Approves Gazyva for Chronic Lymphocytic Leukemia
The US Food and Drug Administration today approved Gazyva ( obinutuzumab ) for use in combination with chlorambucil to treat patients with previously untreated chronic lymphocytic leukemia (CLL).
Wait, I Didn’t Know That About Blood Cancer!
Since there is no screening test for blood cancers, early detection is a challenge. But advances in blood cancer treatments are helping patients live longer, more fulfilling lives.
A Booster Shot for Leukemia
Bone marrow transplants are a possible treatment for chronic lymphocytic leukemia, a type of blood cancer, when it cannot be controlled by chemotherapy.
Blood Cancer Rx Trial Halted
The purpose of clinical trials is to study the safety and effectiveness of a medication. Sometimes, clinical trials involving humans find that a medication does not work and the study is stopped. This just happened in a trial looking at a blood cancer medication.
Cancer Outcomes Tied to Your Genes
As screening tests and treatments for cancer have improved, patients are living longer. However, some patients don't respond to treatment as well as others.
Leukemia Survival Rates Have Soared
There have been numerous recent advances in cancer therapies and technologies. Some of them aim to cure cancer and others try to make lives better for those fighting the disease.
Leukemia Rx May Work Well
Chronic lymphocytic leukemia is a type of blood cancer that usually grows slowly and can be treated with chemotherapy. But in some cases, patients do not respond to this traditional treatment.
Updating Info on CML Rx
Chronic myeloid leukemia (CML) was once a dire diagnosis. Now the disease can be treated successfully in most people. The disease has to be treated over many years to be kept under control.
These Cells Can Stem Blood Cancer
Being diagnosed with leukemia or lymphoma can be a major life change for patients. With new advances in medicine, they may have some respite.
New and Improved Leukemia Rx
Though more common in adults, acute myeloid leukemia (AML) is the second most common type of blood cancer in children. If untreated, the disease can be fatal in just a few months.